H.10 additional manufacturer narrative: the aquabeam robotic system was not returned for investigation of this event and is currently in use at the user facility.The investigation consisted of a review of the information reported to procept, plus a review of the device history record (dhr),and labeling.The treatment log files were not made available for review.A review of the device history record (dhr) ab2000-b / serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 4.3.Warnings: procedure as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: o bleeding.Section 8.32 states the following: a.After the aquabeam handpiece removal, follow the standard clot evacuation procedure to remove clots and tissue with a cystoscopic sheath by using an ellik bladder evacuator or toomey syringe.B.Use one of the following methods to achieve hemostasis: · cautery followed by foley balloon catheter insertion.· under spinal anesthesia, insert a balloon catheter in the bladder with bladder neck traction then fill the bladder with sterile saline and maintain for approximately 30-60 minutes before starting cbi (continuous bladder irrigation) · balloon catheter in bladder with bladder neck traction · balloon catheter in prostatic fossa: o inflate balloon with 5cc in the bladder o under trus guidance retract balloon into prostatic fossa o inflate balloon to 30-50% of initial prostate volume o apply mild traction on the catheter to hold the balloon catheter in place · balloon catheter in bladder, no traction.C.Start cbi per hospital protocol.The device was not returned for investigation because it performed as intended during the aquablation procedure.From the description of the event, the issue is associated with achieving adequate hemostasis post-aquablation, which was later addressed by taking the patient back into the operating room (or) for further cauterization.The aquabeam robotic system instructions for use list bleeding as a potential risk of the aquablation procedure and provide adequate instructions on how to achieve appropriate hemostasis.Based on the review of the information provided, plus a review of the dhr and ifu this event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|